Prolonged Response to HER2-Directed Therapy in a Patient With HER2-Amplified, Rapidly Progressive Metastatic Colorectal Cancer. [electronic resource]
Producer: 20171016Description: 3-8 p. digitalISSN:- 1540-1413
- Ado-Trastuzumab Emtansine
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Biopsy
- Camptothecin -- administration & dosage
- Chemoradiotherapy, Adjuvant
- Colorectal Neoplasms -- diagnosis
- DNA Mutational Analysis -- methods
- Disease Progression
- Drug Resistance, Neoplasm
- Fluorouracil -- administration & dosage
- Gene Amplification
- High-Throughput Nucleotide Sequencing
- Humans
- Laparoscopy
- Leucovorin -- administration & dosage
- Liver Neoplasms -- genetics
- Male
- Maytansine -- administration & dosage
- Middle Aged
- Molecular Targeted Therapy -- methods
- Off-Label Use
- Palliative Care -- methods
- Proto-Oncogene Proteins c-myc -- genetics
- Receptor, ErbB-2 -- genetics
- Tomography, X-Ray Computed
- Trastuzumab
- Tumor Suppressor Protein p53 -- genetics
- Ultrasonography
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.